Back to Search
Start Over
Identification of causative gene variants for patients with known monogenic diabetes using a targeted next-generation sequencing panel in a single-center study.
- Source :
-
Diabetology international [Diabetol Int] 2023 Nov 15; Vol. 15 (2), pp. 203-211. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2024). - Publication Year :
- 2023
-
Abstract
- Aims: We aimed to verify the usefulness of targeted next-generation sequencing (NGS) technology for diagnosing monogenic diabetes in a single center.<br />Methods: We designed an amplicon-based NGS panel targeting 34 genes associated with known monogenic diabetes and performed resequencing in 56 patients with autoantibody-negative diabetes mellitus diagnosed atβ<β50 years who had not been highly obese. By bioinformatic analysis, we filtered significant variants based on allele frequency (<β0.005 in East Asians) and functional prediction. We estimated the pathogenicity of each variant upon considering the family history.<br />Results: Overall, 16 candidate causative variants were identified in 16 patients. Among them, two previously known heterozygous nonsynonymous single-nucleotide variants associated with monogenic diabetes were confirmed as causative variants: one each in the GCK and WFS1 genes. The former was found in two independent diabetes-affected families. Two novel putatively deleterious heterozygous variants were also assumed to be causative from the family history: one frameshift and one nonsynonymous single-nucleotide variant in the HNF4A gene. Twelve variants remained as candidates associated with the development of diabetes.<br />Conclusion: Targeted NGS panel testing was useful to diagnose various forms of monogenic diabetes in combination with familial analysis, but additional ingenuity would be needed for practice.<br />Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-023-00669-3.<br />Competing Interests: Conflict of interestThe authors declare that they have no conflict of interest.<br /> (© The Japan Diabetes Society 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)
Details
- Language :
- English
- ISSN :
- 2190-1678
- Volume :
- 15
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Diabetology international
- Publication Type :
- Academic Journal
- Accession number :
- 38524932
- Full Text :
- https://doi.org/10.1007/s13340-023-00669-3